You can rationalize yourself into your preferred outcome as much as you want. But you won't be able to evaporate that this is a pitcher who hasn't been able to stay on the field the last couple of years. Sure, go ahead if you like, and announce that there's no reason to have a heightened concern that this particular pitcher will have trouble staying on the field over the next 3 years. But I guarantee you that zero teams are actually thinking that, including the Mets. It's a matter of who wants to spend big bucks while also rolling the dice to a greater extent than you would with a other mid-30s pitcher with no recent arm problems. The thing that will draw other teams (not sure how many) is how great deGrom is when he's healthy. How much this deal will cost will be, to a large extent, driven by whether and, if so, how many, teams other than the Mets are willing to risk 3+ years and big bucks on a guy like this. As is no surprise, all of that is unclear right now.